Get the Weekly Intelligence Brief — top committee picks every Sunday.

BKD vs MRK

Brookdale Senior Living Inc. vs Merck & Co. — AI-powered side-by-side comparison
BKD
Brookdale Senior Living Inc.
51
Watch
VS
MRK
Merck & Co.
70
Buy
MetricBKDMRK
AI Score 51 70
Price $12.56 $130.34
P/E Ratio -21.68× 103.53×
ROE 587.0% 34.7%
Revenue Growth YoY
Gross Margin 14.4% 75.4%
Debt / Equity -44.49× 1.29×
Dividend Yield 0.0% 2.6%
RSI (14) 15.7 64.5
Beta 0.609 0.207
Expected Upside

AI Committee View

Current Innellis committee reasoning for BKD versus MRK.
MRK leads by 19 points.

MRK scores 70/100 (Buy) versus BKD at 51/100 (Watch).

BKD Committee View
50% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 18.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • RSI at 16 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading below the lower Bollinger Band -- stretched to the downside — Technical
MRK Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BKD Full Analysis MRK Full Analysis